2019 Speaker Highlightsoctaneoc.org/wp-content/uploads/2019/09/MTIF-2019-Agenda-09.1… · more...

9

Transcript of 2019 Speaker Highlightsoctaneoc.org/wp-content/uploads/2019/09/MTIF-2019-Agenda-09.1… · more...

Page 1: 2019 Speaker Highlightsoctaneoc.org/wp-content/uploads/2019/09/MTIF-2019-Agenda-09.1… · more data is necessary to determine its clinical benefit and global effect on the United
Page 2: 2019 Speaker Highlightsoctaneoc.org/wp-content/uploads/2019/09/MTIF-2019-Agenda-09.1… · more data is necessary to determine its clinical benefit and global effect on the United

2

2019 Speaker Highlights

M T I F 2 0 1 9O C T O B E R 2 8 - 2 9 , 2 0 1 9

N E W P O R T B E A C H M A R R I O T T H O T E L & S P A

Page 3: 2019 Speaker Highlightsoctaneoc.org/wp-content/uploads/2019/09/MTIF-2019-Agenda-09.1… · more data is necessary to determine its clinical benefit and global effect on the United

7:15 – 8:15 AM Registration, Networking, 1x1 Meetings & Exhibits

8:15 – 8:30 AM Welcome Address: Building the SoCal of Tomorrow

OCTANe CEO Bill Carpou opens up the 2019 Medical Technology Innovation Forum with a focus on the current MedTech ecosystem in Southern California and what the future holds for growth in Orange County

8:30 – 9:15 AM Keynote: AI Med- Artificial Intelligence in Medicine

Dr. Anthony Chang- Chief Intelligence & Innovation Officer, CHOC

9:15 - 10:00 AM Future of Health Care- The Role of Personalized Medicine?

Better diagnoses, earlier interventions, more-efficient drug therapies, customized treatment plans. These are the promises of personalized medicine. Individualized, precision or personalized medicine provides a genomic blueprint to determine each person's unique disease susceptibility, define preventive measures and enable targeted therapies to promote wellness. Our panelists will provide their unique perspectives on what the future holds for personalized medicine.

Steve Keiles, Senior Director, Genomic Services, Advanced Diagnostics, Quest DiagnosticsPatrick Lilley, Founder & CEO, Liquid BiosciencesAnnette Walker, President, City of HopeShaista Malik, MD, PhD, MPH, Associate Vice Chancellor, Integrative Health & Executive Director, Susan Samueli Integrative Health

Institute

10:00 - 10:30 AM Break & 1x1 Meetings

3

Day 1: Monday, October 28, 2019

M T I F 2 0 1 9O C T O B E R 2 8 - 2 9 , 2 0 1 9

N E W P O R T B E A C H M A R R I O T T H O T E L & S P A

Page 4: 2019 Speaker Highlightsoctaneoc.org/wp-content/uploads/2019/09/MTIF-2019-Agenda-09.1… · more data is necessary to determine its clinical benefit and global effect on the United

4

11:15 - 11:45 AM Break & 1x1 Meetings

11:45 – 12:45 PM Lunch- Keynote Speaker- Jim Fallon- Professor, UCI, Neuroscientist, Best Selling Author

Through research he explores the way genetic and perinatal environmental factors affect the way the brain gets built -- and then how an individual's experience further shapes his or her development. But has Fallon’s research on psychopaths and murderers made a strange and personal turn. With PET scans and genetics , he uncovered the deep, underlying traits that make people violent and murderous.

Day 1: Monday, October 28, 2019

M T I F 2 0 1 9O C T O B E R 2 8 - 2 9 , 2 0 1 9

N E W P O R T B E A C H M A R R I O T T H O T E L & S P A

1:00 - 1:45 PM Industry Track- Healthcare-On-The-Go

Panel participants will focus on the future of care, the changing medical landscape, and whether telemedicine makes healthcare more affordable.

Jessica Achtsam, Partner, Knobbe Martens (Moderator)Dr. Justin Zaghi, Medical Director, Heal.comJenna Mons, CEO, CONCIERGE KEY Health, Inc.Robert Allison, Principal & Managing Director, Innovate

Partners

1:00 – 1:45 PM International Track- Reality Check-Doing Business in China

This session will focus on the the challenges of doing business in China: avoiding the pitfalls and how to find trusted partners while doing business in the country.

John Cox, President & CEO, FRESCA Medical (Moderator)Chris Lo, Director, Hong Kong Trade Development CouncilJim Mayfield, Director, US Export Assistance CenterPaul DeRidder, MD, MBA, President, BioValleyCHINAAndrew Pan, Senior Vice President & Head, East West Bank’s

China Business & Strategy

12:45 - 1:00 PM Break & 1x1 Meetings

10:30 - 11:15 AM Industry Track – Clinical Trials

Focusing on the challenges with clinical trials- recruitment, capturing information, reimbursement and the payer perspective.

Bruce Feuchter, Shareholder, Stradling (Moderator)Janice Sidorick, CEO, Janix (CRO) Marina Bejanian, PhD, Executive Director, Clinical

Development, AllerganKaren Davis, Vice President of Clinical Research, Vertos Medical

10:30 - 11:15 AM International Track- EU RegulatoryUpdate: MDR/IVDR/ Brexit

An update on current status of BREXIT. What does BREXIT mean for companies in the US and Britain? What are the tax and legal implications? What are the implications for doing business in the rest of Europe?

Kevin Depew, Deputy Chief Economist, RSM (Moderator)Mike Howells, Consul General, British ConsulateAlison Dennis, Partner, Field FisherPatrick Johnson, President & CEO, Celluma

Page 5: 2019 Speaker Highlightsoctaneoc.org/wp-content/uploads/2019/09/MTIF-2019-Agenda-09.1… · more data is necessary to determine its clinical benefit and global effect on the United

5

Day 1: Monday, October 28, 2019

3:45 – 4:30 PM Panel Discussion :The State of Affairs for Medical Cannabis

Despite its controversial nature, medical marijuana use and legal adoption continues to expand nationwide. Currently, there are over 70 completed or ongoing human clinical trials exploring cannabinoid use. However, many questions remain as variations of legal use exist from state to state, and more data is necessary to determine its clinical benefit and global effect on the United States health care system.

Kim Kovacs, President, Los Angeles Venture Association (LAVA), & CEO, MyJane (Moderator)Dan Torpey, Partner, EY

4:30 - 4:45PM Closing Address Day 1

4:45 - 6:00 PM Reception

3:00 – 3:45 PM Panel Discussion: Medical Innovation in Aesthetics

Panelists in this session will facilitate the exchange of insights on emerging trends and innovation in medical aesthetics.

Dr. Scott Whitcup, Founder and CEO, Akrivista and Whitecap Biosciences (Moderator)Dr. Edward Ross, Dermatologist, ScrippsDr. Chris Zachary, Chair & Professor - Dermatology, UC Irvine School of MedicineDr. Natasha Mesinkovska, Dermatology Specialist, UC Irvine Medical CenterDr. Steve Yoelin, Cosmetic SurgeonDarin Messina, Vice President of Device Biology R&D, Allergan

M T I F 2 0 1 9O C T O B E R 2 8 - 2 9 , 2 0 1 9

N E W P O R T B E A C H M A R R I O T T H O T E L & S P A

2:30 - 3:00 PM Break & 1x1 Meetings

1:45 - 2:30PM Industry Track- Future of Mental Health

Hear from leaders of Be Well OC- a transformative first of its kind-initiative bringing together public, private, academic and faith based based organizations to coordinate a coordinated system of mental health and support. What is the latest innovation in mental health treatment? How do you personalize treatment?

Dr. Rick Afable, President & Board Member, MindOCMarshall Monchief, CEO, MindOCDr. Clayton Chau, Chief Clinical Officer, MindOC

1:45 - 2:30PM International Track- Healthcare Around the WorldHealthcare varies around the world with almost all wealthy nations providing universal health care (the US is an exception). Due to the costs required as well as various social, cultural, political and economic conditions, healthcare is challenging to get right. Learn from other countries about how their healthcare systems are evolving and what innovative steps are they taking. Learn about the landscape for MedTech start-ups and companies doing business in other countries and the advantages to being based outside the United States and what opportunities are there available.

Linda DiMario, Executive Vice President, Greater Irvine Chamber of Commerce (Moderator)

Page 6: 2019 Speaker Highlightsoctaneoc.org/wp-content/uploads/2019/09/MTIF-2019-Agenda-09.1… · more data is necessary to determine its clinical benefit and global effect on the United

7:30 – 9:00 AM Registration, Networking, 1x1 Meetings & Exhibits

9:15 – 9:20 AM Kick Off Day Two

Day Two will start off with a preview of the day’s agenda.

Bill Carpou, CEO, OCTANe

9:30 - 10:00 AM Keynote : Mike Mussallem CEO, Edwards Lifesciences

Introduction by: Ken Beall, Founder, University Lab PartnersMike Mussallem CEO, Edwards Lifesciences

6

10:00 - 10:45 AM Investor/Private Equity Panel

This session will provide various perspectives and an overview from corporate strategic investors, venture capital investors, investor masterminds as it relates to MedTech Investments.

Jim Mazzo, Global President Ophthalmic Devices, ZEISS (Moderator)Michael Hedge, Managing Partner, K&L GatesGilbert Kliman, General Partner & Managing Director, InterWest PartnersDoug Fisher, Executive in Residence, InterWest PartnersJim Boylan, President & Head of Investment Banking, SVBLeerinkMichael Giaquinto, Senior Managing Director, SVBLeerinkGeorge Wall, Partner & Chair – M&A, Glaser Weil

Day 2: Tuesday, October 29, 2019

M T I F 2 0 1 9O C T O B E R 2 8 - 2 9 , 2 0 1 9

N E W P O R T B E A C H M A R R I O T T H O T E L & S P A

8:00 – 9:00 AM Breakfast with the Experts

ThisyearatMTIF,OCTANe iscreatingthefirsteverBreakfastwiththeExpertsnetworkingbreakfast.Attendeeswillgetachancetosign-upfortheopportunitytospeaktosomeofOrangeCounty’smostprominentmedtech experts.Theseexpertswillbemadeupofinvestors,C-levelexecutives,entrepreneurs,LaunchPadalumniandexpertsintheirfield

Page 7: 2019 Speaker Highlightsoctaneoc.org/wp-content/uploads/2019/09/MTIF-2019-Agenda-09.1… · more data is necessary to determine its clinical benefit and global effect on the United

7

10:45 – 11:15 AM Networking Break & 1x1 Meetings

Day 2: Tuesday, October 29, 2019

M T I F 2 0 1 9O C T O B E R 2 8 - 2 9 , 2 0 1 9

N E W P O R T B E A C H M A R R I O T T H O T E L & S P A

11:15 - 12:00 AM Panel: Buying and Selling Healthcare Technology Companies: Thoughts on Integration and Exit

Dominique Worthington, Sr. Director Strategy & Portfolio Management, HPMS and Integration, Medtronic (Moderator)Stanton Rowe, CEO, NXT BiomedicalJeff Margolis, Chairman and CEO, WelltokAzadeh Nasabi, Sr. Director - Strategy & Business Development, Brain Therapies, MedtronicRyan Keefer, Partner - Merger and Acquisition Integration Group, PwC

12:00 – 12:30PM Break & 1x1 Meetings

12:30 - 1:45 PM Lunch Panel: Women in MedTech Lunch

Keynote Speaker- Trish Costello, CEO, Portfolia

This panel will discuss leading a medtech companies that are start-ups, focused on women’s health and the challenges they have faced.

Kelly Barba, Associate Director of Business Development, K&L Gates (Moderator)Sabrina Johnson, CEO, Daré BioscienceLubna Ahmad, CEO, Invoy TechnologiesFei Li, President and CEO, HYCOR BiomedicalNatalie Dakers, President and CEO, Accel-Rx Health Sciences Accelerator

1:45 – 2:00 PM Break & 1x1 Meetings

Page 8: 2019 Speaker Highlightsoctaneoc.org/wp-content/uploads/2019/09/MTIF-2019-Agenda-09.1… · more data is necessary to determine its clinical benefit and global effect on the United

2:00 – 3:45 PM LaunchPad SBDC Company Presentations

A highlight of each year’s Medical Technology Innovation Forum (MTIF) are the presentations by companies who have recently been through the LaunchPadSBDC evaluation process. These companies have been selected from a pool of over 100 applicants and represent a diverse group of life science technologies. This year, eight companies will be presenting. Since 2010, LaunchPad companies who have presented at MTIF have raised over $650 million in investment.

David Mildrew, Managing Director, BioQuest (Moderator)

8

4:00 –4:15 PM LaunchPad SBDC Award

4:15 -4:30 PM Closing Day 2: Tying it All Together

Recap of the top takeaways from MTIF 2019

Bill Carpou, CEO, OCTANeJim Mazzo, MTIF Chairman, OCTANe

Day 2: Tuesday, October 29, 2019

M T I F 2 0 1 9O C T O B E R 2 8 - 2 9 , 2 0 1 9

N E W P O R T B E A C H M A R R I O T T H O T E L & S P A

3:45 –4:00 PM LaunchPad Success Story

Rick Sanghera, Co-Founder & CEO at AtaCor Medical, Inc.

Page 9: 2019 Speaker Highlightsoctaneoc.org/wp-content/uploads/2019/09/MTIF-2019-Agenda-09.1… · more data is necessary to determine its clinical benefit and global effect on the United